Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19764 | 427 | 21.0 | 49% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 3744 | 706 | POLYNUCLEOTIDE ANALOGUE//QUIM FARMACEUT ORGAN//BENZODIOXEPINS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | QUIM FARMACEUT ORGAN | Address | 5 | 23% | 4% | 19 |
| 2 | BENZODIOXEPINS | Author keyword | 5 | 63% | 1% | 5 |
| 3 | IN VIVO ANTITUMOUR ACTIVITY | Author keyword | 5 | 63% | 1% | 5 |
| 4 | IN VIVO ANTITUMOR ACTIVITY | Author keyword | 4 | 33% | 3% | 11 |
| 5 | MEDIUM MOLECULAR WEIGHT | Author keyword | 4 | 75% | 1% | 3 |
| 6 | BIOPATOL MED REGENERAT IBIMER | Address | 4 | 40% | 2% | 8 |
| 7 | AVERAGE MOLECULAR WEIGHTS | Author keyword | 3 | 57% | 1% | 4 |
| 8 | 4 AMINO N 2 PYRIMIDINYL BENZENE SULFONAMIDE | Author keyword | 3 | 100% | 1% | 3 |
| 9 | BENZOXATHIEPINS | Author keyword | 3 | 60% | 1% | 3 |
| 10 | ANAT EMBRIOL HUMANA | Address | 2 | 19% | 3% | 12 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 5 FLUOROURACIL DERIVATIVES | 13 | 53% | 4% | 17 |
| 2 | O N ACETALS | 6 | 71% | 1% | 5 |
| 3 | 4 AMINO N 2 PYRIMIDINYL BENZENE SULFONAMIDE | 3 | 100% | 1% | 3 |
| 4 | POLYOXYETHYLENE CO OXYPROPYLENE | 1 | 100% | 0% | 2 |
| 5 | N ACYL | 1 | 12% | 2% | 9 |
| 6 | 1 4 DIOXEPANE | 1 | 50% | 0% | 1 |
| 7 | 2 O METHYLURIDINE | 1 | 50% | 0% | 1 |
| 8 | 5 NITROURACIL | 1 | 50% | 0% | 1 |
| 9 | 6 AZATHYMINE | 1 | 50% | 0% | 1 |
| 10 | ANTI TUMOR ACTIVITIES | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Development of 5-Fluorouracil Derivatives as Anticancer Agents | 2011 | 12 | 50 | 32% |
| From 5-fluorouracil acyclonucleosides to benzo-fused six- and seven-membered rings linked to pyrimidine and purine bases: the shift from differentiating anticancer agents to apoptotic inducers | 2008 | 2 | 43 | 44% |
| From a classic approach in cancer chemotherapy towards differentiation therapy: Acyclic and cyclic seven-membered 5-fluorouracil O,N-acetals | 2000 | 12 | 34 | 26% |
| Design, Synthesis and Anticancer Activity Against the MCF-7 Cell Line of Benzo-Fused 1,4-Dihetero Seven- and Six-Membered Tethered Pyrimidines and Purines | 2008 | 4 | 74 | 24% |
| SYNTHESIS OF FTORAFURE (REVIEW) | 1991 | 2 | 8 | 88% |
| New medium oxacyclic O,N-acetals and related open analogues: Biological activities | 2005 | 6 | 65 | 25% |
| NEW ASPECTS OF POLYMER DRUGS | 1990 | 13 | 33 | 30% |
| Acyclonucleosides, Modified Seco-Nucleosides, and Salicyl- or Catechol-Derived Acyclic 5-Fluorouracil O,N-Acetals: Antiproliferative Activities, Cellular Differentiation and Apoptosis | 2009 | 2 | 61 | 18% |
| Emerging peptide therapeutics for inflammatory diseases | 2006 | 8 | 25 | 4% |
| In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications | 2015 | 0 | 74 | 7% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | QUIM FARMACEUT ORGAN | 5 | 23% | 4.4% | 19 |
| 2 | BIOPATOL MED REGENERAT IBIMER | 4 | 40% | 1.9% | 8 |
| 3 | ANAT EMBRIOL HUMANA | 2 | 19% | 2.8% | 12 |
| 4 | PREMED SCI | 2 | 17% | 3.0% | 13 |
| 5 | BIOPATHOL MED REGENERAT IBIMER | 1 | 50% | 0.5% | 2 |
| 6 | BIOSANIT GRANADA IBS GRANADA | 1 | 50% | 0.5% | 2 |
| 7 | MED PHYS BIOPHYS IMAGE DIAGNOST | 1 | 50% | 0.2% | 1 |
| 8 | NAT BION | 1 | 50% | 0.2% | 1 |
| 9 | OPEN MOL ENGN POLYMERS | 1 | 50% | 0.2% | 1 |
| 10 | PHARMACEUT SCI RADIOCHEM | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000130090 | DIFFUSION CELL EXPERIMENTS//TRANSFORMED POTTS GUY EQUATION//ROBERTS SLOAN EQUATION |
| 2 | 0.0000109603 | POLYNUCLEOTIDE ANALOGUE//DEPYRIMIDINATION//ADENOSINE IMMOBILIZED SILICA |
| 3 | 0.0000106050 | TULAREMIA LIVE VACCINE//1 HEXYLCARBAMOYL 5 FLUOROURACIL//5 FLUOROURACIL AND 1 HEXYLCARBAMOYL 5 FLUOROURACIL |
| 4 | 0.0000105827 | MOUSE LYMPHOID NEOPLASMA P 388//MOUSE MAMMARY CARCINOMA FM 3A//HUMAN HISTIOCYTIC LYMPHOMA U 937 |
| 5 | 0.0000087174 | HPMA COPOLYMERS//HPMA COPOLYMER//POLYMER THER EUT |
| 6 | 0.0000087016 | CHIM PHARMACEUT LILLE//PYROGLUTAMIC DERIVATIVES//CHIM ORGAN ENVIRONM |
| 7 | 0.0000070431 | 1 3 DIOXEPINS//1 CHLORO 2 NITROBENZENE//DIHYDROBENZODITHIEPINES |
| 8 | 0.0000053585 | PROTON TRANSFER COMPOUNDS//DADA ARRAY//DNA RNA NUCLEOBASES |
| 9 | 0.0000051237 | CHAIN COPOLYMERIZATION//INHIBITORS OF AGGREGATION//INVIVO CULTURE |
| 10 | 0.0000047631 | ACYCLIC NUCLEOSIDE PHOSPHONATES//ACYCLIC NUCLEOSIDE PHOSPHONATE//PMEA |